Clinical Trials for Halozyme Therapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Halozyme Therapeutics

Clinical Trials (3)

NCT06689085
52 Week Study of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
PHASE3Recruiting
100 participants
Started: Feb 5, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor13 locations
NCT03281369
A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)
PHASE1/PHASE2Active, not recruiting
410 participants
Started: Oct 13, 2017 · Completed: Nov 30, 2025
1 condition3 sponsors27 locations
NCT02921022
Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma
NAActive, not recruiting
110 participants
Started: Oct 31, 2016 · Completed: Oct 31, 2025
2 conditions3 sponsors10 locations